Expression of tal-1 and GATA-binding proteins during human hematopoiesis.

Tal-1 rearrangements are associated with nearly 30% of human T acute lymphoblastic leukemia. Tal-1 gene encodes a putative transcription factor with a basic helix-loop-helix domain and is known to be predominantly expressed in hematopoietic cells. We investigated the pattern of tal-1 expression in purified human hematopoietic cells by in situ hybridization and reverse transcriptase polymerase chain reaction analysis. Both methods demonstrated that the tal-1 gene is expressed in megakaryocytes and erythroblasts as well as in basophilic granulocytes. In addition, our results indicate that the tal-1 1A promoter, which contains two consensus GATA-binding sites, is active mainly in these lineages. Because the GATA-1 gene is known to transactivate several genes specific for the erythroid, megakaryocytic, and mastocytic/basophilic lineages, we studied GATA-1 expression in these purified hematopoietic cells. We found that GATA-1 and tal-1 genes are coexpressed in these three lineages. Remarkably, the expression of both genes is downmodulated during erythroid and megakaryocytic terminal maturation. In immature hematopoietic cells, tal-1 and GATA-1 genes are coexpressed in committed progenitors cells (CD34+/CD38(2+)), whereas they are not detectable in the most primitive cells (CD34(2+)/CD38-). In contrast, GATA-2 is strongly expressed in both most primitive and committed progenitors cells, whereas GATA-3 is mostly detected in most primitive ones. Altogether our results strongly suggest that GATA-1 modulates the transcription of tal-1 during the differentiation of the erythroid, megakaryocytic, and basosophilic lineages.

[1]  R. Berger,et al.  A third tal-1 promoter is specifically used in human T cell leukemias , 1992, The Journal of experimental medicine.

[2]  W. Vainchenker,et al.  c-jun and c-fos are expressed by human megakaryocytes. , 1992, Experimental hematology.

[3]  J. Visvader,et al.  SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. , 1992, Oncogene.

[4]  H. Sather,et al.  Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. , 1992, Blood.

[5]  A. Green,et al.  Antisense SCL suppresses self‐renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. , 1991, The EMBO journal.

[6]  S. Raimondi,et al.  c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35). , 1991, Blood.

[7]  I. Kirsch,et al.  Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia , 1991, Molecular and cellular biology.

[8]  R. Berger,et al.  Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene. , 1991, Oncogene.

[9]  H. Hsu,et al.  Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins , 1991, Molecular and cellular biology.

[10]  W. Vainchenker,et al.  In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes. , 1991, Blood.

[11]  M. Surani,et al.  Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression. , 1991, Oncogene.

[12]  S. Tsai,et al.  Human GATA‐3: a lineage‐restricted transcription factor that regulates the expression of the T cell receptor alpha gene. , 1991, The EMBO journal.

[13]  P. Lansdorp,et al.  Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. , 1991, Blood.

[14]  G. Felsenfeld,et al.  trans-Activation of a globin promoter in nonerythroid cells , 1991, Molecular and cellular biology.

[15]  B. Klein,et al.  Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. , 1991, Blood.

[16]  J. Visvader,et al.  Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. , 1991, Oncogene.

[17]  I. Kirsch,et al.  Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. , 1990, Science.

[18]  J. Coligan,et al.  The SCL gene is formed from a transcriptionally complex locus , 1990, Molecular and cellular biology.

[19]  A. Carroll,et al.  Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia , 1990, The Journal of experimental medicine.

[20]  S. Orkin,et al.  Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. , 1990, Genes & development.

[21]  J. D. Engel,et al.  Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. , 1990, Genes & development.

[22]  M. Siciliano,et al.  Site‐specific recombination of the tal‐1 gene is a common occurrence in human T cell leukemia. , 1990, The EMBO journal.

[23]  M. Amylon,et al.  The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1990, Blood.

[24]  Nic Jones,et al.  Transcriptional regulation by dimerization: Two sides to an incestuous relationship , 1990, Cell.

[25]  W. Vainchenker,et al.  Megakaryocytic and erythrocytic lineages share specific transcription factors , 1990, Nature.

[26]  Stuart H. Orkin,et al.  Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages , 1990, Nature.

[27]  A. Carroll,et al.  The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix‐loop‐helix protein. , 1990, The EMBO journal.

[28]  S. Koury,et al.  Purification of human blood burst‐forming units‐erythroid and demonstration of the evolution of erythropoietin receptors , 1990, Journal of cellular physiology.

[29]  R. Berger,et al.  Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T‐cell leukemias , 1990, Genes, chromosomes & cancer.

[30]  T. Waldmann,et al.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Felsenfeld,et al.  The erythroid-specific transcription factor eryf1: A new finger protein , 1989, Cell.

[32]  Y. Jan,et al.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.

[33]  P. Nowell,et al.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[35]  W. Vainchenker,et al.  Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum‐replaced cultures , 1989, Journal of cellular physiology.

[36]  T. Waldmann,et al.  Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  N. Gough Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. , 1988, Analytical biochemistry.

[38]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.